Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway
|更新时间:2025-04-18
|
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway
“The latest research has found that Bu Zhong Yi Qi Tang regulates endoplasmic reticulum stress through the Nrf2/ROS pathway and improves cisplatin resistance in non-small cell lung cancer.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 10, Pages: 98-104(2025)
YU Dan,MU Qirui,LI He,et al.Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(10):98-104.
YU Dan,MU Qirui,LI He,et al.Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(10):98-104. DOI: 10.13422/j.cnki.syfjx.20250121.
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway